Articles
-
Just Say “Climate Change”—Not “Climate Emergency”
The terms “climate change” and “global warming” are more familiar to people and also generate more concern about the planet’s warming.
Categorized in -
Comments to Representatives DeGette and Bucshon on Building on the Successes of 21st Century Cures
Schaeffer Center experts provided comments to lawmakers on additional measures for enhancing or improving the effectiveness of the 21st Century Cures Act.
Categorized in -
State Mandates to Cap Out-of-Pocket Insulin Costs Are No Longer Necessary
State laws capping patients’ out-of-pocket insulin costs, though well-intentioned, have had limited impact.
Categorized in -
Study: Exploding Popularity of Ozempic and Wegovy Among Privately Insured Patients May Worsen Disparities
Publicly insured individuals who are most likely to benefit from new diabetes and obesity drugs are less likely to get them than those with private insurance.
Categorized in -
A Patient-Focused, Evidence-Driven Approach to PBM Reform
As policymakers consider reforms to the prescription drug supply chain, they should keep five principles in mind to ensure better outcomes for patients.
Categorized in -
Comments to CMS on Transcatheter Tricuspid Valve Replacement (TTVR) and Broader CED Policy Considerations
Schaeffer Center experts provided comments to CMS on issues with how Coverage with Evidence Determination policy is applied.
Categorized in -
2024 Alzheimer’s Trial Recruitment Innovation Lab Fellowship Program — Application Open
The University of Southern California (USC) announces an opening for a fellow to join the Alzheimer’s Trial Recruitment Innovation Lab (ATRIL) fellowship program in the fall of 2024.
Categorized in -
Schaeffer Institute Launches New Initiative to Improve Public Policy
Climate change, health and food insecurity will be major focuses of a new initiative aimed at creating policies and communication that better fit people’s needs.
Categorized in -
Study: Americans Find Hospital-at-Home Care Appealing and Safe
Most people see hospital-level care provided in a patient’s home as convenient, comfortable and effective.
Categorized in -
Estimating Overpayments to MA Plans: MedPAC Critics Get It Wrong
Why many of the key assertions in a recent Forefront article challenging the MedPAC’s estimate that favorable selection and upcoding increase payments to Medicare Advantage (MA) plans in 2024 by $83 billion are wrong.
Categorized in